SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy.
Jae Kyu RyuElif G SozmenKaruna DixitMauricio MontanoYusuke MatsuiYixin LiuEkram HelmyThomas J DeerinckZhaoqi YanRenaud SchuckRosa Meza AcevedoCollin M SpencerReuben ThomasAlexander R PicoScott S ZamvilKara L LynchMark H EllismanWarner C GreeneKaterina AkassoglouPublished in: bioRxiv : the preprint server for biology (2021)
SARS-CoV-2 spike induces structurally abnormal blood clots and thromboinflammation neutralized by a fibrin-targeting antibody.